Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.

A nutrition and food science expert says there are three pills we should all be taking at this time of year - not just vitamin D. Lucy Kershaw of Nature’s Best said colder months affect our health, ...

Florida’s Republican Legislators want to make it easier to get ivermectin, the controversial anti-parasitic drug. Tucked into what has been called Florida’s Medical Freedom bill is a provision that ...

Louisiana’s attorney general is preparing to sue California Gov. Gavin Newsom and New York Gov. Kathy Hochul in federal court in an effort to force those states to extradite doctors who face criminal ...

Iowa Republicans are considering a bill to allow over-the-counter access to the anti-parasitic drug ivermectin. Medical professionals and the FDA have warned against general human use of ivermectin, ...

Taking a closer look at how teams with winning records have fared against other squads over .500 so far this season. John Schuhmann The Rockets and Pistons are among the NBA’s best in both overall win ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

California Gov. Gavin Newsom (D) on Wednesday rejected the request from Louisiana officials to extradite a California doctor accused of illegally mailing abortion medication. “Louisiana’s request is ...

Abortion debate heats up after arrest of Kentucky woman who allegedly took abortion pills. The prosecution of a Kentucky woman who allegedly took abortion pills is firing up both sides of the abortion ...

BATON ROUGE, La.—For the second year in a row, the Dietary Approaches to Stop Hypertension, or DASH Diet, developed in part by scientists at Pennington Biomedical Research Center, has been recognized ...

SAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk (NOVOb.CO), opens new tab executive said on Monday, a ...